Federal Court allows Janssen to amend statement of defence in litigation with Apotex

By Heidi Exner (October 28, 2022, 3:57 PM EDT) -- The Federal Court has allowed Janssen Inc. leave to amend its statement of defence in ongoing litigation with Apotex Inc., but has dismissed the innovator drugmaker’s motion to have evidence heard together....